These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study. Paciaroni M, Agnelli G, Caso V, Pieroni A, Bovi P, Cappellari M, Zini A, Nichelli P, Inzitari D, Nesi M, Nencini P, Pezzini A, Padovani A, Tassinari T, Orlandi G, Chiti A, Gialdini G, Alberti A, Venti M, Acciarresi M, D'Amore C, Luda E, Tassi R, Martini G, Ferrarese C, Beretta S, Trentini C, Silvestrelli G, Lanari A, Previdi P, Ciccone A, Delodovici ML, Bono G, Galletti G, Marcheselli S, Del Sette M, Traverso E, Riva M, Silvestrini M, Cerqua R, Consoli D, Monaco S, Toni D. Cerebrovasc Dis; 2012; 34(5-6):430-5. PubMed ID: 23207482 [Abstract] [Full Text] [Related]
4. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator. Chung JW, Kim KJ, Noh WY, Jang MS, Yang MH, Han MK, Kwon OK, Jung C, Kim JH, Oh CW, Lee JS, Lee J, Bae HJ. Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898 [Abstract] [Full Text] [Related]
8. Results of intravenous thrombolysis within 4.5 to 6 hours and updated results within 3 to 4.5 hours of onset of acute ischemic stroke recorded in the Safe Implementation of Treatment in Stroke International Stroke Thrombolysis Register (SITS-ISTR): an observational study. Ahmed N, Kellert L, Lees KR, Mikulik R, Tatlisumak T, Toni D, SITS Investigators. JAMA Neurol; 2013 Jul; 70(7):837-44. PubMed ID: 23689267 [Abstract] [Full Text] [Related]
15. Efficacy of intravenous thrombolysis according to stroke subtypes: the Madrid Stroke Network data. Fuentes B, Martínez-Sánchez P, Alonso de Leciñana M, Egido J, Reig-Roselló G, Díaz-Otero F, Sánchez V, Simal P, Ximenez-Carrillo A, García-Pastor A, Ruiz-Ares G, García-García A, Masjuan J, Vivancos-Mora J, Gil-Nuñez A, Díez-Tejedor E, Madrid Stroke Network. Eur J Neurol; 2012 Dec; 19(12):1568-74. PubMed ID: 22742869 [Abstract] [Full Text] [Related]
16. Factors influencing clinical outcomes of acute ischemic stroke treated with intravenous recombinant tissue plasminogen activator. Huang YH, Zhuo ST, Chen YF, Li MM, Lin YY, Yang ML, Chen ZJ, Cai RW. Chin Med J (Engl); 2013 Dec; 126(24):4685-90. PubMed ID: 24342312 [Abstract] [Full Text] [Related]
19. [Impact of a stroke-unit on rtPA use in a community hospital: a 3-year prospective study]. Barroso B, Demasles S, Debeugny S, Bertandeau E, Bonnan M, Chauveau M, Dakar A, Krim E. Rev Neurol (Paris); 2013 Apr; 169(4):307-13. PubMed ID: 23523017 [Abstract] [Full Text] [Related]
20. Intravenous Thrombolysis for Acute Ischemic Stroke due to Cervical Internal Carotid Artery Occlusion. Yeo LL, Kong WY, Paliwal P, Teoh HL, Seet RC, Soon D, Rathakrishnan R, Ong V, Lee TH, Wong HF, Chan BP, Leow WK, Yuan C, Ting E, Gopinathan A, Tan BY, Sharma VK. J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2423-9. PubMed ID: 27344361 [Abstract] [Full Text] [Related] Page: [Next] [New Search]